M20-098 ABBV-951 aPD
ClinicalTrials.gov NCT04750226
Research payments
$42,549
Through program year 2024, $42,549 in research payments was reported against M20-098 ABBV-951 aPD, across 28 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT04750226
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $42,549 | 28 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nicki Niemann Phoenix, AZ Named on 1 payment
- Paolo Moretti Salt Lake City, UT Named on 1 payment
- Arjun Tarakad Houston, TX Named on 1 payment
- Irene Litvan Louisville, KY Named on 1 payment
- Michael Soileau Georgetown, TX Named on 1 payment
- Daniel Claassen Nashville, TN Named on 1 payment
- Rajeev Kumar Englewood, CO Named on 1 payment
- Mwiza Ushe Saint Louis, MO Named on 1 payment
- Drew Kern Aurora, CO Named on 1 payment
- Khashayar Dashtipour Loma Linda, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.